Summary
The Infections with opportunistic pathogens represent one of the major problems in the management of immunocompromised hosts, especially in surgical, trauma, burn, cancer patients and in the case of patients heavily treated with radiotherapy or chemotherapy (1) . Methicillin-resistant strains of Staphylococcus aureus (MRSA) have emerged as a frequent cause of nosocomial infections world-wide (2) . Most of the strains are virulent and can produce a fatal generalized disease. The morbidity, mortality, and costs associated with treatment and prevention of MRSA Infections are substantial (3), and thus any therapy that would prevent infection or enhance the host defense mechanisms would be beneficial.
Glutamine has been classified as a nonessential or nutritionally dispensable amino acid (4) . As a result of this classification, it has been eliminated from total parenteral nutritional formulas and most enteral formulas include only small quantities or are devoid of glutamine. More recently, glutamine has been shown to improve immunologic, physiologic, and metabolic functions in laboratory and clinical studies. Supplemental dietary glutamine has been shown to act as a vehicle for the transfer of nitrogen between tissues (5), a regulator of protein synthesis (6) , an essential precursor for nucleic acid biosynthesis in all cells (7), enhances lymphocyte responses to mitogens (8) , decreases bacteremia and endotoxemia, improves nitrogen balance and survival in methotrexate and 5-fluorouracil-induced enterocolitis in rats (9, 10) . For these reasons, the present study was undertaken to see the effect of glutamine supplementation on response to MRSA challenge.
Materials and methods. Thirty BALB/c female mice, 4weeks old, were randomized into 3 groups and maintained daily throughout a 30-day period on the following diets: Group A mice were fed 20% casein diet (control), whereas Groups B and C mice were fed 20% casein diet supplemented with 2 and 4% glutamine, respectively. The diets were isonitrogenous by glycine and alanine supplementa tion. Table 1 shows the composition of the diets used. The mice had access to food and water ad libitum. From 10 to 11 a. m. every morning, the animals were weighed and food and water were renewed. the glutamine supplementation could offer significant protection following induc tion of sepsis; however, from our studies it is evident that it may exceed 7.6%. Glutamine has been categorized as a nutritionally dispensable amino acid (4). Since this classification implies that glutamine can be synthesized endogenously in adequate quantities from other amino acids and precursors, it has not been considered necessary to include glutamine in nutritional formulas. However, growing evidence shows that glutamine supplementation regulates various steps of the metabolic physiologic, and immunologic functions (5-9). Whereas much attention has been focused on the use of glutamine in the management of septic or immunocompromised patients, relatively few studies have attempted conclusively to define the optimal dosage required for efficient metabolic, physiologic, and immunologic functions. Karner et al. (14) showed that supplementation of total parenteral nutrition (TPN) with 0.37g glutamine or glycylglutamine/kg body weight (equivalent to about 10% glutamine in TPN) in dogs after surgery was not sufficient to restore glutamine deficiency of the skeletal muscle in the depleted state. Hammarqvist et al. (15) documented that supplementation of TPN with 0.285g glutamine/kg body weight per day for 3days (equivalent to about 7% glutamine in TPN) improved nitrogen balance and protein synthesis in catabolic patients. Ardawi (16) , and Klimberg et al. (17) showed that 2 and 3% glutamine-enriched TPN improved nitrogen balance, mucosal morphometrics, and survival in septic and whole abdominal radiation-treated rats for 4 and 8days, respectively. Our studies also demonstrated that 5.6% dietary glutamine (3.6% in casein plus 2% supplementation) was not adequate in offering protection to the mice. These and other studies suggest that the optimal dosage of glutamine needed to improve or maximize the metabolic, physiologic, and immunologic functions is not clear or well defined. Further studies will prove useful in determining the precise dose required for maintenance and regulation of the physiologic, metabolic, and im munologic functions. Such studies are currently in progress in our laboratory.
In summary, the present result suggest that glutamine may be used to an advantage to enhance the immune system of the mice following MRSA challenge.
